Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118710692 | 11871069 | 2 | F | 20160825 | 20151228 | 20160825 | EXP | US-BRISTOL-MYERS SQUIBB COMPANY-14777650 | BRISTOL MYERS SQUIBB | 26.00 | YR | F | Y | 0.00000 | 20160825 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118710692 | 11871069 | 1 | PS | STAVUDINE. | STAVUDINE | 1 | Oral | 40 MG, QD | 20412 | 40 | MG | QD | |||||||
| 118710692 | 11871069 | 2 | SS | COMBIVIR | LAMIVUDINEIDOVUDINE | 1 | Oral | 2 DF, QD | 0 | 2 | DF | QD | |||||||
| 118710692 | 11871069 | 3 | SS | KALETRA | LOPINAVIRRITONAVIR | 1 | Oral | 4 DF, QD | 0 | 4 | DF | QD | |||||||
| 118710692 | 11871069 | 4 | SS | EPIVIR | LAMIVUDINE | 1 | Oral | 300 MG, QD | 0 | 300 | MG | QD | |||||||
| 118710692 | 11871069 | 5 | SS | RETROVIR | ZIDOVUDINE | 1 | Intravenous (not otherwise specified) | 2 MG/KG, QH | Y | 0 | 2 | MG/KG | /hr | ||||||
| 118710692 | 11871069 | 6 | SS | RETROVIR | ZIDOVUDINE | 1 | Intravenous (not otherwise specified) | 1 MG/KG, UNK | Y | 0 | 1 | MG/KG | /hr |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118710692 | 11871069 | 1 | Antiretroviral therapy |
| 118710692 | 11871069 | 2 | Antiretroviral therapy |
| 118710692 | 11871069 | 3 | Antiretroviral therapy |
| 118710692 | 11871069 | 4 | Antiretroviral therapy |
| 118710692 | 11871069 | 5 | Antiretroviral therapy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118710692 | 11871069 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118710692 | 11871069 | Maternal exposure during pregnancy | |
| 118710692 | 11871069 | Oligohydramnios | |
| 118710692 | 11871069 | Premature delivery |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 118710692 | 11871069 | 1 | 20070516 | 0 | ||
| 118710692 | 11871069 | 2 | 20070130 | 0 | ||
| 118710692 | 11871069 | 3 | 20070130 | 0 | ||
| 118710692 | 11871069 | 4 | 20070516 | 0 | ||
| 118710692 | 11871069 | 5 | 20070612 | 20070612 | 0 |